Skip to main content

Table 1 Mortality rates according to socio demographic and clinical characteristics of patients with ischemic and haemorrhagic stroke during 30-day and 90-day follow-up in Kampala, Uganda

From: Predictors of 30-day and 90-day mortality among hemorrhagic and ischemic stroke patients in urban Uganda: a prospective hospital-based cohort study

Baseline characteristics

Overall mortality N = 141

n (col %)

30-day mortality N = 136

(n (%))

30-day mortality rate (95% CI) (Deaths/1000 person days)

P-value

90-day mortality N = 90

(n (%))

90-day mortality rate (95% CI) (Deaths/1000 person days)

P-Value

SOCIO DEMOGRAPHIC CHARACTERISTICS

Age (years)

   

0.036

  

0.039

 - → <  60

60 (43)

8 (5.8)

4.4 (2.21–8.83)

 

5 (5.6)

3.4 (1.96–5.82)

 - → ≥ 60

81 (57)

23 (16.9)

10.4 (6.93–15.7)

 

8 (8.9)

7.0 (4.92–9.96)

Gender

   

0.039

  

0.101

 - → Male

48 (34)

7 (5.1)

3.9 (1.77–8.77)

 

5 (5.6)

3.6 (1.98–6.46)

 - → Female

93 (66)

24 (17.6)

10.0 (6.78–14.8)

 

8 (8.9)

6.3 (4.51–8.92)

Marital status

   

0.205

  

0.037

 -Married

67 (48)

11 (8)

5.6 (3.08–10.0)

 

4 (4.4)

3.6 (2.15–5.92)

 -Widowed

49 (35)

13 (9.5)

9.9 (5.76–17.1)

 

2 (2.2)

5.5 (3.34–9.18)

Divorced/separated

16 (11)

5 (3.7)

13.9 (6.24–30.9)

 

5 (5.5)

11.6 (6.22–21.5)

 -Never married

9 (6)

2 (1.4)

3.42 (0.48–24.3)

 

2 (2.2)

8.1 (3.03–21.5)

Education level

   

0.396

  

0.823

 -No education

20 (14)

6 (4.4)

10.9 (4.91–24.3)

 

–

5.3 (2.38–11.8)

 -Primary

56 (40)

8 (5.9)

5.5 (2.87–10.6)

 

8 (8.8)

4.7 (2.88–11.8)

 -Secondary +

65 (46)

17 (12.5)

8.7 (5.34–14.2)

 

5 (5.5)

5.9 (3.87–8.93)

Smoking

   

0.020

  

0.125

- → No

31 (22)

2 (1.5)

2.0 (0.50–8.05)

 

4 (4.4)

3.1 (1.40–6.92)

- → Yes

110 (78)

29 (21.3)

9.6 (6.67–13.8)

 

9 (10.0)

6.0 (4.36–8.23)

Alcohol use

   

0.071

  

0.057

 -Low risk drinkers

105 (74)

27 (19.9)

9.3 (6.37–13.5)

 

10 (11.1)

6.4 (4.64–8.83)

 -Harmful/high risk

36 (26)

4 (2.9)

3.6 (1.36–9.60)

 

3 (3.3)

2.8 (1.34–5.89)

Family history of DM

   

0.634

  

0.901

- → Yes

103 (73)

17 (12.5)

7.3 (4.71–11.2)

 

9 (10.0)

5.3 (3.70–7.48)

- → No

38 (27)

14 (10.3)

8.7 (4.70–16.2)

 

4 (4.4)

5.5 (3.17–9.40)

Family history of HTN

   

0.906

  

0.557

- → Yes

92 (65)

21 (15.4)

7.9 (5.20–12.2)

 

11 (12.2)

6.0 (4.26–8.52)

- → No

33 (23)

7 (5.1)

7.9 (3.77–16.6)

 

1 (1.1)

4.3 (2.12–8.49)

- → Don’t know

16 (12)

3 (2.2)

6.0 (1.94–18.6)

 

1 (1.1)

3.7 (1.39–9.90)

 

CLINICAL CHARACTERISTICS

Self-reported history of HTN

   

0.995

  

0.563

- → Yes

83 (59)

18 (13.2)

7.7 (4.92–12.1)

 

8 (8.8)

5.0 (3.39–7.42)

- → No

58 (41)

13 (9.6)

7.7 (4.40–13.6)

 

5 (5.5)

5.8 (3.69–9.07)

Self-reported history of DM

   

0.489

  

0.333

- → Yes

28 (20)

7 (5.1)

9.6 (4.78–19.1)

 

4 (4.4)

7.2 (4.08–12.6)

- → No

113 (80)

24 (17.6)

7.2 (4.81–10.9)

 

9 (10)

4.9 (3.43–6.85)

BP ≥ 140/90

   

0.292

  

0.272

- → Yes

82 (58)

21 (15.4)

8.9 (5.86–13.9)

 

9 (10.0)

6.1 (4.26–8.71)

- → No

59 (42)

10 (7.4)

6.0 (3.20–11.1)

 

4 (4.4)

4.2 (2.48–7.06)

Obese

   

0.766

  

0.372

- → Yes

29 (21)

6 (4.4)

6.9 (3.09–15.3)

 

1 (1.1)

4.0 (1.90–8.36)

- → No

112 (79)

25 (18.4)

7.9 (5.37–11.8)

 

12 (13.3)

5.7 (4.11–7.84)

HIV infection

   

0.294

  

0.751

- → Yes

27 (19)

2 (1.5)

4.8 (1.79–12.7)

 

4 (4.4)

4.9 (2.46–9.84)

- → No

114 (81)

27 (20.5)

8.5 (5.83–12.4)

 

9 (10.0)

5.4 (3.91–7.51)

Duration of hospitalization

   

0.015

  

0.004

Mean duration ±SD

9.4 (10.7)

      

 - < 7 days

78 (55)

17 (12.5)

7.4 (4.54–12.1)

 

5 (5.5)

4.4 (2.89–6.80)

 

 -7–13 days

37 (26)

6 (4.4)

4.3 (1.78–10.2)

 

5 (5.5)

4.7 (2.58–8.40)

 -14–29 days

17 (12)

7 (5.2)

20.2 (10.5–38.8)

 

3 (3.3)

17.5 (9.7–31.6)

 - ≥ 30 days

9 (7)

1 (0.5)

4.2 (0.59–30.0)

 

–

1.8 (0.26–13.0)

 

Glasgow Coma Scale (GCS)

   

< 0.001

  

< 0.001

Mean GCS ± SD

12 (2.8)

 

11.0 (3.2)

  

13.3 (2.4)

 - < 9

21 (15)

11 (8.1)

28.6 (15.8–51.6)

 

2 (2.2)

20.9 (12.1–35.9)

 - ≥ 9

120 (85)

20 (14.7)

5.5 (3.55–8.54)

 

11 (12.2)

4.1 (2.85–5.76)

Stroke severity at enrolment

      

< 0.001

Mean NIHSS ±SD

15 (10.1)

 

20.0 (10.7)

< 0.001

 

13.2 (9.0)

 -NIHSS 0–12

66 (47)

7 (5.1)

2.8 (1.28–6.32)

 

4 (4.4)

2.4 (1.33–4.35)

 -NIHSS 13–20

33 (23)

6 (4.4)

7.8 (3.74–16.4)

 

4 (4.4)

5.3 (2.87–9.91)

 -NIHSS ≥21

42 (30)

18 (13.2)

17.9 (11.3–28.3)

 

5 (5.5)

12.6 (8.34–18.9)

Stroke type

   

0.079

  

0.123

 Ischemic stroke

90 (64)

16 (11.8)

5.92 (3.63–9.67)

 

9 (10.0)

4.4 (2.98–6.53)

 Hemorrhagic stroke

51 (36)

15 (11.0)

11.4 (6.89–18.9)

 

4 (4.4)

7.3 (4.65–11.4)

History of stroke

   

0.334

  

0.977

 -Yes

20 (14)

6 (4.4)

11.3 (5.08–25.2)

 

–

5.4 (3.90–7.37)

 -No

121 (86)

25 (18.4)

7.2 (4.85–10.6)

 

13 (14.4)

5.1 (2.28–11.3)

Pre-stroke functional status

   

0.998

  

0.804

 -mRS 0–2

132 (93)

29 (21.3)

7.7 (5.37–11.1)

 

12 (13.3)

5.3 (3.92–7.23)

 -mRS 3

5 (4)

1 (0.7)

7.4 (1.04–52.2)

 

1 (1.1)

7.5 (1.87–29.0)

 -mRS 4–5

4 (3)

1 (0.7)

7.9 (1.11–55.9)

 

–

3.3 (0.46–23.1)

Functional status at enrolment

   

0.016

  

0.009

 -mRS 0–3

31 (22)

2 (1.5)

1.9 (0.48–7.69)

 

2 (2.2)

1.8 (0.66–4.68)

 

 -mRS 4–5

110 (78)

29 (21.3)

9.8 (6.77–14.0)

 

11 (12.2)

6.7 (4.89–9.09)

 
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us